Drug Database
Back to search

Switzerland· 47366002

Lutrelef 3,2 mg, Injektionspräparat

A gonadorelin product, registered in Switzerland by Ferring AG and dispensed under Swissmedic category B. The same ATC class is registered in 5 of our 19 countries.

Cat B (Swissmedic)ATC H01CA01

Checked against the register on

Informational only — not a medical device.

SOURCE REGISTER · CHPublic registernormalisedLutrelef 3,2 mg, InjektionspräparatATCH01CA01REGISTER NO.47366002PACKS LISTED0CHECKEDJune 26, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about LutrelefAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Gonadorelin is registered in 5 of 19 countries.

Countries holding a registration under ATC H01CA01 (gonadorelin), each read from that country’s own register.

  • This record: Switzerland
  • 2 of them publish a price we can compare per daily dose
Search gonadorelin products by name

Gonadorelin · ATC H01CA01

5 / 19 countries

  • Canada
  • Finlandprice
  • Japan
  • Netherlands
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Manufacturer
Ferring AG
Country
Switzerland (CH)
ATC code
H01CA01
ATC class
Gonadorelin
Swissmedic category
B
Reimbursed
No
Last checked
June 26, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

1 interaction on record for gonadorelin.

Graded by severity as the source publishes them — 1 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check gonadorelin against other medicinesHow interaction checks work

Gonadorelin · interactions on record

1 record

  • 1 moderate

Most severe, free to view

  • GanirelixH01CC01moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same class

Other records under H01CA01

Gonadorelin, as other registers publish it.

All gonadorelin products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of the issuing authority. This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/4f29a0de-9119-4939-9a9f-023aa2321ce5
GET /v1/drugs/4f29a0de-9119-4939-9a9f-023aa2321ce5?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "source": "swissmedic_auth",
  "heilmittelcode": "Biotechnologika"
}
API referenceMCP serverPlans

See everything about gonadorelin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console